Nanalysis Scientific Income Statement

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	40.13	45.5	28.47	24.82	16.04
Revenue Growth (YoY)	-11.79%	59.82%	14.69%	54.72%	103.75%
Cost of Revenue	30.17	32.75	24.5	14.35	5.8
Gross Profit	9.96	12.75	3.97	10.47	10.24
Selling, General & Admin	9.71	10.27	11.37	12.94	7.69
Research & Development	0.43	0.54	0.68	1.47	0.64
Operating Expenses	13.73	16.19	17.46	20.52	11.43
Operating Income	-3.77	-3.45	-13.49	-10.06	-1.19
Interest Expense	-1.37	-1.35	-0.28	-0.08	-
Interest & Investment Income	-	-	-	-	0
Earnings From Equity Investments	-	-1.09	-0.53	-	-
Currency Exchange Gain (Loss)	0.04	-0.03	-0.17	-0.16	-0.04
Other Non Operating Income (Expenses)	-0.52	-0.5	-	-	-
EBT Excluding Unusual Items	-5.62	-6.4	-14.46	-10.3	-1.23
Merger & Restructuring Charges	-0.05	-0.31	0.53	-0.1	-0.19
Gain (Loss) on Sale of Investments	-	-4.64	-	-	-
Gain (Loss) on Sale of Assets	0.04	-0.09	-2.86	-	-
Asset Writedown	-	-1.46	-	-	-
Other Unusual Items	-	-0.73	-	-	-0.35
Pretax Income	-5.64	-13.64	-16.8	-10.4	-1.77
Income Tax Expense	0.02	-0.02	-0.01	-0.48	-
Earnings From Continuing Operations	-5.66	-13.61	-16.78	-9.92	-1.77
Minority Interest in Earnings	-	-	0.59	0.81	-
Net Income	-5.66	-13.61	-16.2	-9.1	-1.77
Net Income to Common	-5.66	-13.61	-16.2	-9.1	-1.77
Shares Outstanding (Basic)	115	111	99	92	70
Shares Outstanding (Diluted)	115	111	99	92	70
Shares Change (YoY)	3.68%	11.56%	7.25%	31.35%	7.77%
EPS (Basic)	-0.05	-0.12	-0.16	-0.10	-0.03
EPS (Diluted)	-0.05	-0.12	-0.16	-0.10	-0.03
Free Cash Flow	3.17	3.21	-11.92	-10.67	-1.79
Free Cash Flow Per Share	0.03	0.03	-0.12	-0.12	-0.03
Gross Margin	24.83%	28.02%	13.95%	42.18%	63.83%
Operating Margin	-9.38%	-7.57%	-47.38%	-40.51%	-7.42%
Profit Margin	-14.10%	-29.92%	-56.90%	-36.67%	-11.04%
Free Cash Flow Margin	7.90%	7.05%	-41.88%	-43.00%	-11.18%
EBITDA	-3.11	-2.41	-12.33	-8.81	-0.57
EBITDA Margin	-7.76%	-5.30%	-43.32%	-35.47%	-3.58%
D&A For EBITDA	0.65	1.03	1.16	1.25	0.62
EBIT	-3.77	-3.45	-13.49	-10.06	-1.19
EBIT Margin	-9.38%	-7.57%	-47.38%	-40.51%	-7.42%
Revenue as Reported	40.13	45.5	28.47	24.82	16.04

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.